FindTrial
Sign In

Risk Prediction and Evaluation of Intravenous Thrombolytic Hemorrhage Conversion in Acute ischemic stroke patients Based on Machine Learning

Risk Prediction and Evaluation of Intravenous Thrombolytic Hemorrhage Conversion in Acute ischemic stroke patients Based on Machine Learning

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022924
Enrollment
Unknown
Registered
2019-05-03
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute ischemic stroke

Interventions

acute ischemic stroke:intervenous thrombolysis

Sponsors

Shanghai 6th People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Acute ischemic stroke patients with intravenous thrombolysis treatment

Exclusion criteria

Exclusion criteria: Acute ischemic stroke patients without intervenous thrombolysis treatment

Design outcomes

Primary

MeasureTime frame
Symptomatic intracranial hemorrhage;—

Secondary

MeasureTime frame
mRS score on 90d;—

Countries

China

Contacts

Public ContactFeng Wang

Shanghai 6th People's Hospital

wangfeng_doctor@126.com+86 18930173523

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026